Of dogs showing clinical flea allergy dermatitis ( FAD ) signs at the study start , 85.7 % in the Bravecto ( fluralaner ) - treated group and 55.6 % in the Frontline ( fipronil ) - treated group were evaluated at each time point as showing no clinical signs of FAD until study completion .